O2 investigators meeting

October 30, 2018
endTB clinical trial investigators and study coordinators successfully complete first annual Investigators Meeting in Paris.

endTB clinical trial investigators and study coordinators successfully complete first annual Investigators Meeting in Paris.

endTB clinical trial investigators and study coordinators successfully complete first annual Investigators Meeting in Paris. Attendance and enthusiasm are high with participation from all countries currently active (Georgia, Kazakhstan, Lesotho, Peru, and South Africa) in the trial and from Pakistan, which is scheduled to begin randomization in early 2019. The meeting coincided with randomization of the 169th participant of a total of 750.

PIH MSF MSF UNITAID